Tuberculosis News and Research

Latest Tuberculosis News and Research

U.S. Administration to provide $5 billion to the Global Fund to Fight AIDS, Tuberculosis and Malaria

In an address recognizing World AIDS Day, President Barack Obama announced today that the U.S. Administration will commit up to $5 billion to the Global Fund to Fight AIDS, Tuberculosis and Malaria over the next three years. Specifically, he said the United States will contribute $1 for every $2 provided by other donors worldwide through 2016, up to $5 billion.

3 Dec 2013

Newly identified protein could prove promising new drug target for AIDS

Researchers have identified a protein that causes loss of function in immune cells combatting HIV. The scientists report in a paper appearing online Dec. 2 in the Journal of Clinical Investigation that the protein, Sprouty-2, is a promising target for future HIV drug development, since disabling it could help restore the cells' ability to combat the virus that causes AIDS.

2 Dec 2013

WHO releases new report on spinal cord injury

As many as 500 000 people suffer a spinal cord injury each year. People with spinal cord injuries are 2 to 5 times more likely to die prematurely, with worse survival rates in low- and middle-income countries. The new WHO report, "International perspectives on spinal cord injuries", summarizes the best available evidence on the causes, prevention, care and lived experience of people with spinal cord injury.

2 Dec 2013

World AIDS Day: (RED) invites the world to join in fight against AIDS

World AIDS Day marks a time to celebrate how far we've come in the fight to end AIDS, as well as a time to shine a global spotlight on the monumental, historical opportunity now upon us to deliver the world's first AIDS Free Generation in over 30 years.

30 Nov 2013

Medical Research Council should do more in the development of gold standard for clinical trial design

More should be done to celebrate the role of one of Britain’s leading institutions, the Medical Research Council, in the development of the gold standard for clinical trial design. Sir Iain Chalmers, writing in the Journal of the Royal Society of Medicine, questions the apparent reluctance of the MRC to take credit for its ground-breaking work in the design and management of randomised multicentre controlled clinical trials in the 1950s.

28 Nov 2013

UK to fund over 70 new Centres for Doctoral Training

Details of how a -350 million fund will be used to train over 3,500 postgraduate students in engineering and physical sciences, will be announced today by Universities and Science Minister, David Willetts.

28 Nov 2013

New NIH guidelines for managing opportunistic infections in children with HIV

Sharon Nachman, MD, a pediatric HIV and infectious diseases specialist at Stony Brook Children's Hospital, is a co-author of new National Institutes of Health (NIH)-issued guidelines for the prevention, treatment and management of opportunistic infections in HIV-exposed and HIV-infected children. The 2013 guidelines shed light on the most effective way to treat dangerous and deadly infections such as pneumonia or tuberculosis that can strike immunosuppressed pediatric HIV patients.

27 Nov 2013

MSF launches film series to counterbalance rhetoric presenting the fight against HIV/AIDS as almost won

The fight against HIV/AIDS has been hailed as one of the most successful public health projects in human history, but teams from the international medical humanitarian organisation Médecins Sans Frontières/Doctors Without Borders (MSF) see the revolution as unfulfilled for millions of people excluded from treatment.

26 Nov 2013

New concept outlines steps to tackle neglected tropical diseases, expedite poverty reduction efforts

A new concept and policy framework published in PLOS NTDs outlines concrete steps for the global development community as it works to synthesize health goals with economic, environmental and social priorities.

26 Nov 2013

Global health organizations join forces to raise awareness on dangers of fake medicines

Fake medicines increasingly put patients and the general public at risk across the world. In response to this challenge, ten partners who represent healthcare professionals, disease-specific organizations, product-development partnerships, foundations, international financing institutions, as well as the research-based pharmaceutical industry have joined forces to raise awareness about the dangers of fake medicines.

26 Nov 2013

Researchers identify key immune cells that turn body's defenders against invading golden staph

When golden staph enters our skin it can identify the key immune cells and 'nuke' our body's immune response.

26 Nov 2013

CHMP recommends approval of Otsuka's Deltyba for pulmonary multidrug-resistant tuberculosis

Otsuka Pharmaceutical Co., Ltd. today announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency has recommended approval of Deltyba (delamanid) in combination with a WHO recommended optimized background regimen for the treatment of pulmonary multidrug-resistant tuberculosis (MDR-TB). The CHMP opinion will help form the basis for a European Commission decision expected early next year.

25 Nov 2013

Bangladesh outperforms Asian neighbours despite low spending on health care

Exceptional improvements in the survival of infants and children under 5 years of age, life expectancy, immunisation coverage, and tuberculosis control in Bangladesh are part of a remarkable success story for health in the South Asian country, according to a major new Series published in The Lancet. This is despite low spending on health care, a weak health system, and widespread poverty.

21 Nov 2013

Call to recognize lung diseases as leading causes of morbidity and mortality

Experts from the world's leading lung organisations have come together for the first time to call for a worldwide effort to improve healthcare policies, systems and care delivery to make a positive difference to the lung health of the world.

20 Nov 2013

Advanced cytotoxins help bacteria survive antibiotics treatment

In spite of the fact that the first antibiotics were discovered almost a century ago, infectious diseases such as tuberculosis, encephalitis and meningitis are still serious diseases for humans in the twenty-first century. The World Health Organization (WHO) estimates that there are more than 8 million new cases of tuberculosis per year on a global scale, and that more than 300,000 of these are due to multidrug-resistant strains that are not only difficult to treat, but are also emerging rapidly in regions such as Eastern Europe.

20 Nov 2013

WHO continues to coordinate deployment of foreign medical teams in Philippines

More than 10 days after Super Typhoon Haiyan devastated the central Philippines, WHO is continuing to coordinate the deployment of foreign medical teams with an immediate focus on injured and traumatized survivors and an eye towards the people's longer-term health needs.

20 Nov 2013

ORC to develop paper-based sensors to detect biomarkers in cancer patients

Pioneering research by the Optoelectronics Research Centre that could transform the care of cancer patients or people with infections in their own homes has received a significant grant from the Engineering and Physical Sciences Research Council.

19 Nov 2013

New biomedical instrument anticipated to help breakthroughs in animal, human health

A Kansas State University team recently received a nearly $1.3 million grant from the National Science Foundation's Major Research Institute for a biomedical instrument that is anticipated to help with breakthroughs in animal and human health as well as cancer treatment.

13 Nov 2013

Global Coalition Against Child Pneumonia calls for continued investment in innovations, proven tools

Global health advocates today commemorated the fifth annual World Pneumonia Day by calling on global leaders to scale up existing interventions and invest in new diagnostics and treatments to defeat pneumonia. Each year, pneumonia kills more children than AIDS, malaria and tuberculosis combined. Pneumonia took the lives of nearly 1.1 million children under 5 in 2012 alone, with more than 99 percent of these deaths in developing countries, where access to healthcare facilities and treatment is out of reach for many children.

12 Nov 2013

Clinical testing expanded for vaccine against latent TB

Statens Serum Institut and Aeras today announced the initiation of a Phase I/IIa clinical trial for a candidate tuberculosis vaccine designed to protect people, especially those latently infected with TB, from developing active TB disease.

8 Nov 2013

Tuberculosis News and Research

Latest Tuberculosis News and Research

U.S. Administration to provide $5 billion to the Global Fund to Fight AIDS, Tuberculosis and Malaria

Newly identified protein could prove promising new drug target for AIDS

WHO releases new report on spinal cord injury

World AIDS Day: (RED) invites the world to join in fight against AIDS

Medical Research Council should do more in the development of gold standard for clinical trial design

UK to fund over 70 new Centres for Doctoral Training

New NIH guidelines for managing opportunistic infections in children with HIV

MSF launches film series to counterbalance rhetoric presenting the fight against HIV/AIDS as almost won

New concept outlines steps to tackle neglected tropical diseases, expedite poverty reduction efforts

Global health organizations join forces to raise awareness on dangers of fake medicines

Researchers identify key immune cells that turn body's defenders against invading golden staph

CHMP recommends approval of Otsuka's Deltyba for pulmonary multidrug-resistant tuberculosis

Bangladesh outperforms Asian neighbours despite low spending on health care

Call to recognize lung diseases as leading causes of morbidity and mortality

Advanced cytotoxins help bacteria survive antibiotics treatment

WHO continues to coordinate deployment of foreign medical teams in Philippines

ORC to develop paper-based sensors to detect biomarkers in cancer patients

New biomedical instrument anticipated to help breakthroughs in animal, human health

Global Coalition Against Child Pneumonia calls for continued investment in innovations, proven tools

Clinical testing expanded for vaccine against latent TB

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Tuberculosis News and Research

Latest Tuberculosis News and Research

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Newsletters you may be interested in